The phrase "analysis demonstrated no differences" is correct and usable in written English.
It can be used in contexts where research or data analysis has been conducted, and the results indicate that there are no significant differences between the groups or variables being studied.
Example: "The analysis demonstrated no differences in the outcomes between the control group and the experimental group, suggesting that the treatment had no effect."
Alternatives: "analysis revealed no differences" or "analysis showed no differences".
However, further analysis demonstrated no differences in overall tumor vascularity (data not shown), suggesting that while vascular integrity is impaired in Cd34−/− mice, CD34 ablation has no observable effect on general tumor angiogenesis.
Stereological analysis demonstrated no differences between the two groups (Fig. 4b).
In our study, a subgroup analysis demonstrated no differences between off-pump and on-pump surgery for tissue oxygenation.
Western blot analysis demonstrates no differences in ChAT or TrkA levels at postnatal day 7, a time point when no behavioral or cellular deficits are present.
A sensitivity analysis demonstrated no difference between methods in the final model (data not shown).
Post-hoc analysis demonstrated no difference in the incidence of cognitive impairment between hypothermic and normothermic groups [ 20].
Not only were significantly less macrophages identified as F4/80+ cells, collected from p65+/− muscle (Supplementary Figure S1B), but also ex vivo analysis demonstrated no difference in Hgf expression and only a small, nonsignificant difference in HGF secretion (Supplementary Figure S1C).
The results of our FACS analysis demonstrated no difference in the expression levels of survivin-ΔEx3 or -2B, whereas survivin-WT was overexpressed in PBMCs (in particular CD14+ cells) from SSc patients compared with HCs.
As the results of the analysis demonstrated no difference in mortality, length of stay, or recurrent infection, cost analysis in Canadian dollars evaluated acquisition costs of antibiotics, administration costs of intravenous antibiotics, and PCT testing costs, including assay material, reagents, technician time, purchase, maintenance of a bench top analyzer, and overhead.
Interim analysis demonstrated no difference between PRANDIAL and BASAL treatments with respect to risk for the first combined adjudicated cardiovascular event in type 2 diabetic patients with a recent AMI, and the trial was halted for statistical futility under advice of the Data Monitoring Committee.
Pooled analysis demonstrated no significant differences in the ICU LOS and hospital LOS between the two groups, with a standard difference in the means of −0.08 day (95% CI −0.26 to 0.09) and −0.11 day (95% CI −0.37 to 0.16), respectively (Additional file 1: Figs. S5, S6).
